Skip to main content
OpenTrials

Clinical trial condition

Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer

Explore clinical trials studying Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer trial results

Recruiting

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

NCT06374459

Conditions
Breast Diseases, Breast Neoplasms, Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer, +4 more
Locations
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details

Related conditions